Clinical trial

An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes

NCT01022112

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-11-01

PhasePHASE2

Study timeline

Study start (unknown)2009-11-01Date precision: month

Registry last updated2026-01-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

TA-7284-LowDRUG

TA-7284-Low-middleDRUG

TA-7284-High-middleDRUG

TA-7284-HighDRUG

PlaceboDRUG

Sponsors & collaborators

Tanabe Pharma Corporationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01022112 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.